4T1-hCD47
品系基本信息
驗(yàn)證數(shù)據(jù)
Fig1. hCD47 expression on in vitro cultured cells of 4T1-hCD47. (In collaboration with CrownBio)
Fig2. In vivo validation of 4T1-hCD47 in hSIRPA/hCD47 (BALB/c) mice. (In collaboration with CrownBio) hSIRPA/hCD47 Balb/C mice were inoculated subcutaneously with 4T1 at 3×105 and 4T1-hCD47 at 3×106 cells/mouse inoculum for tumor development.
Fig3. hCD47 expression in tumors after in vivo growth of 4T1-hCD47 in hSIRPA/hCD47(BALB/c) mice. (In collaboration with CrownBio) The tumors were collected at day 35 and day 40 post tumor cell inoculation.
你也可能感興趣
Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下,在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài);當(dāng)Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類似物)與ERT結(jié)合,可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見的基因工程小鼠可以分為兩種命名方式,包括基因定點(diǎn)修飾的小鼠命名,比如:敲除、敲入、點(diǎn)突變等等,和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看